Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
British Journal of Gastroenterology
|
June 22, 2023
Amixicile: A Concept Therapeutic for Treatment of Chronic Anaerobic Infections
Paul S Hoffman
Antibiotics (Basel, Switzerland)
|
May 2, 2020
Antibacterial Discovery: 21st Century Challenges
Paul S Hoffman
Applied and Environmental Microbiology
|
June 6, 2006
Cysteine metabolism in Legionella pneumophila: characterization of an L-cystine-utilizing mutant
Fanny Ewann, Paul S Hoffman
Expert Opinion on Investigational Drugs
|
January 8, 2010
Newer antibacterial drugs for a new century
Gina Devasahayam, William M Scheld, Paul S Hoffman
Journal of Oral Biosciences
|
November 10, 2019
Amixicile targets anaerobic bacteria within the oral microbiome
Qin Gui, Paul S Hoffman, Janina P Lewis
The FEBS Journal
|
May 15, 2009
Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori
Igor N Olekhnovich, Avery Goodwin, Paul S Hoffman
Antimicrobial Agents and Chemotherapy
|
January 30, 2016
Nitazoxanide Inhibits Pilus Biogenesis by Interfering with Folding of the Usher Protein in the Outer Membrane
Peter Chahales, Paul S Hoffman, David G Thanassi
Applied and Environmental Microbiology
|
September 18, 2012
Germination and amplification of anthrax spores by soil-dwelling amoebas
Rafik Dey, Paul S Hoffman, Ian J Glomski
Molecular Microbiology
|
March 8, 2011
DsbA2 (27 kDa Com1-like protein) of Legionella pneumophila catalyses extracytoplasmic disulphide-bond formation in proteins including the Dot/Icm type IV secretion system
Max Jameson-Lee, Rafael A Garduño, Paul S Hoffman
Journal of Bacteriology
|
March 6, 2007
Antisense RNA modulation of alkyl hydroperoxide reductase levels in Helicobacter pylori correlates with organic peroxide toxicity but not infectivity
Matthew A Croxen, Peter B Ernst, Paul S Hoffman
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
British Journal of Gastroenterology
|
June 22, 2023
Amixicile: A Concept Therapeutic for Treatment of Chronic Anaerobic Infections
Paul S Hoffman
Antibiotics (Basel, Switzerland)
|
May 2, 2020
Antibacterial Discovery: 21st Century Challenges
Paul S Hoffman
Applied and Environmental Microbiology
|
June 6, 2006
Cysteine metabolism in Legionella pneumophila: characterization of an L-cystine-utilizing mutant
Fanny Ewann, Paul S Hoffman
Expert Opinion on Investigational Drugs
|
January 8, 2010
Newer antibacterial drugs for a new century
Gina Devasahayam, William M Scheld, Paul S Hoffman
Journal of Oral Biosciences
|
November 10, 2019
Amixicile targets anaerobic bacteria within the oral microbiome
Qin Gui, Paul S Hoffman, Janina P Lewis
The FEBS Journal
|
May 15, 2009
Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori
Igor N Olekhnovich, Avery Goodwin, Paul S Hoffman
Antimicrobial Agents and Chemotherapy
|
January 30, 2016
Nitazoxanide Inhibits Pilus Biogenesis by Interfering with Folding of the Usher Protein in the Outer Membrane
Peter Chahales, Paul S Hoffman, David G Thanassi
Applied and Environmental Microbiology
|
September 18, 2012
Germination and amplification of anthrax spores by soil-dwelling amoebas
Rafik Dey, Paul S Hoffman, Ian J Glomski
Molecular Microbiology
|
March 8, 2011
DsbA2 (27 kDa Com1-like protein) of Legionella pneumophila catalyses extracytoplasmic disulphide-bond formation in proteins including the Dot/Icm type IV secretion system
Max Jameson-Lee, Rafael A Garduño, Paul S Hoffman
Journal of Bacteriology
|
March 6, 2007
Antisense RNA modulation of alkyl hydroperoxide reductase levels in Helicobacter pylori correlates with organic peroxide toxicity but not infectivity
Matthew A Croxen, Peter B Ernst, Paul S Hoffman
Page
of 6